Table 1.

Clinical and Phenotypic Characteristics of EBV+ NK Leukemia

Case Diagnosis Age/SexPeripheral Blood Surface Phenotypes Karyotypes Hepatosplenomegaly Survival (mo)
WBC (/μL) LGL (% of MNC) CD2 CD3 CD7 CD16 CD56
1  NK leukemia 18/M  25,300  96%  99.4  4.3  91.0  1.9  92.0 46XY  +++  5.0  
2  NK leukemia  23/M  5,300 98%  98.2  4.4  79.6  1.1  88.3  NE  +++ 6.0  
3  NK leukemia  75/M  6,700  98%  83.7 1.1  20.5  2.2  82.8  +8,i17(q10)  ++  1.0  
NK leukemia  16/F  23,200  97%  98.3  3.5  87.7 19.3  91.2  NE  ++  0.5  
5  NK leukemia  52/F 12,600  98%  96.5  1.5  2.3  16.1  96.6  NE ++  4.0  
6  NK leukemia  65/M  1,400  96% 54.1  7.2  52.1  0.9  56.3  46XY  +  1.5  
NK leukemia  35/M  12,800  89%  93.4  6.1  79.0 3.0  89.8  46XY  +++  3.0  
8  Chronic NK lymphocytosis  41/M  5,200  47%  76.5  21.0 ND  52.7  53.1  NE  −  >48.0 
Case Diagnosis Age/SexPeripheral Blood Surface Phenotypes Karyotypes Hepatosplenomegaly Survival (mo)
WBC (/μL) LGL (% of MNC) CD2 CD3 CD7 CD16 CD56
1  NK leukemia 18/M  25,300  96%  99.4  4.3  91.0  1.9  92.0 46XY  +++  5.0  
2  NK leukemia  23/M  5,300 98%  98.2  4.4  79.6  1.1  88.3  NE  +++ 6.0  
3  NK leukemia  75/M  6,700  98%  83.7 1.1  20.5  2.2  82.8  +8,i17(q10)  ++  1.0  
NK leukemia  16/F  23,200  97%  98.3  3.5  87.7 19.3  91.2  NE  ++  0.5  
5  NK leukemia  52/F 12,600  98%  96.5  1.5  2.3  16.1  96.6  NE ++  4.0  
6  NK leukemia  65/M  1,400  96% 54.1  7.2  52.1  0.9  56.3  46XY  +  1.5  
NK leukemia  35/M  12,800  89%  93.4  6.1  79.0 3.0  89.8  46XY  +++  3.0  
8  Chronic NK lymphocytosis  41/M  5,200  47%  76.5  21.0 ND  52.7  53.1  NE  −  >48.0 

Abbreviations: WBC, white blood cell count; LGL, large granular lymphocyte; MNC, mononuclear cell; −, negative; +, slight; ++, moderate; +++, huge; NE, no evaluable mitotic cells; ND, not done.

or Create an Account

Close Modal
Close Modal